[{"NetIncomeLoss_1_Q1_USD":-168193.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":190675290.0,"AssetsCurrent_0_Q1_USD":1709025.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":201250000.0,"PaymentsForRent_1_Q1_USD":10000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-201250000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":51250.0,"InterestIncomeOther_1_Q1_USD":331.0,"CommitmentsAndContingencies_0_Q1_USD":null,"GeneralAndAdministrativeExpense_1_Q1_USD":109075.0,"PreferredStockSharesOutstanding_0_Q1_shares":null,"ProceedsFromRelatedPartyDebt_1_Q1_USD":150000.0,"GainLossOnInvestments_1_Q1_USD":331.0,"ProceedsFromRepaymentsOfRelatedPartyDebt_1_Q1_USD":-200000.0,"Liabilities_0_Q1_USD":7284061.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":5168561.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":958372.0,"TemporaryEquityParOrStatedValuePerShare_0_Q1_USD":0.0001,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":5937.0,"SharesIssuedPricePerShare_0_Q1_USD":10.0,"StockIssuedDuringPeriodValueOther_1_Q1_USD":-11455480.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":203057745.0,"ProceedsFromIssuanceOfPrivatePlacement_1_Q1_USD":6025000.0,"AssetsHeldInTrustNoncurrent_0_Q1_USD":201250331.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":6250.0,"RestrictedInvestmentsPercentOfNetAssets_0_Q1_pure":0.2,"PrepaidExpenseCurrent_0_Q1_USD":750653.0,"Cash_0_Q1_USD":958372.0,"PaymentsOfFinancingCosts_1_Q1_USD":4167255.0,"Assets_0_Q1_USD":202959356.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"PropertyPlantAndEquipmentNet_0_Q1_USD":5000001.0,"PreferredStockSharesIssued_0_Q1_shares":null,"CashEquivalentsAtCarryingValue_0_Q1_USD":958000000000.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_1_Q1_USD":10000.0,"BusinessAcquisitionSharePrice_0_Q1_USD":10.0,"AccountsPayableCurrent_0_Q1_USD":140244.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":949572.0,"LiabilitiesCurrent_0_Q1_USD":240311.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-858173.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-169225.0,"TemporaryEquityRedemptionPricePerShare_0_Q1_USD":0.0,"TaxesPayableCurrent_0_Q1_USD":48817.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q1_USD":-190675290.0,"DeferredIncomeNoncurrent_0_Q1_USD":7043750.0,"ProfitLoss_1_Q1_USD":168000.0,"SharePrice_0_Q1_USD":10.0,"BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_0_Q1_pure":1.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":202959356.0,"PreferredStockValue_0_Q1_USD":null,"DebtInstrumentFeeAmount_0_Q1_USD":200000.0,"SaleOfStockConsiderationReceivedOnTransaction_1_Q1_USD":201300000.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q1_USD":201250000.0,"OperatingIncomeLoss_1_Q1_USD":-168524.0,"EquityMethodInvestmentOwnershipPercentage_0_Q1_pure":0.5,"ProductionTaxExpense_1_Q1_USD":49449.0,"StockholdersEquity_0_Q1_USD":5000005.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":750653.0,"Ticker":"PRDS","CIK":"1822711","name":"FS DEVELOPMENT CORP. II","OfficialName":"Pardes Biosciences Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"505269868.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210517"}]